TSE:WEED Canopy Growth (WEED) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free WEED Stock Alerts C$11.59 -0.19 (-1.61%) (As of 05/31/2024 ET) Add Compare Share Share Today's RangeC$11.40▼C$11.9950-Day RangeC$8.43▼C$20.4552-Week RangeC$3.74▼C$26.00Volume1.19 million shsAverage Volume2.88 million shsMarket CapitalizationC$869.83 millionP/E RatioN/ADividend Yield4.80%Price TargetC$3.78 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Get Canopy Growth alerts: Email Address Canopy Growth MarketRank™ Stock AnalysisAnalyst RatingReduce1.50 Rating ScoreUpside/Downside67.4% DownsideC$3.78 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.56Based on 9 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.04 out of 5 stars 0.8 Analyst's Opinion Consensus RatingCanopy Growth has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.Amount of Analyst CoverageCanopy Growth has only been the subject of 1 research reports in the past 90 days.Read more about Canopy Growth's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for WEED. Previous Next 1.7 Dividend Strength Dividend LeadershipCanopy Growth is a leading dividend payer. It pays a dividend yield of 4.80%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCanopy Growth does not have a long track record of dividend growth.Read more about Canopy Growth's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for WEED. Previous Next 2.5 News and Social Media Coverage News SentimentCanopy Growth has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Canopy Growth this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for WEED on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Canopy Growth insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.27% of the stock of Canopy Growth is held by insiders.Percentage Held by InstitutionsOnly 13.95% of the stock of Canopy Growth is held by institutions.Read more about Canopy Growth's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Canopy Growth is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Canopy Growth is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Canopy Growth, their PEG ratio cannot be calculated.Price to Book Value per Share RatioCanopy Growth has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Canopy Growth's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Canopy Growth Stock (TSE:WEED)Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.Read More WEED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WEED Stock News HeadlinesMay 30 at 4:08 PM | gurufocus.comCanopy Growth Corp (CGC) Q4 FY2024 Earnings: Revenue Beats Estimates with 7% YoY Increase, ...May 30 at 5:16 AM | americanbankingnews.comCanopy Growth (TSE:WEED) Trading Down 4.2%May 29 at 3:55 PM | msn.comCanopy Growth Q4 Earnings Preview: Flat results expected this quarter as market evolvesMay 29 at 10:55 AM | finance.yahoo.comWhy the moment for cannabis drinks is not yet upon usMay 28 at 7:14 AM | msn.com3 Sorry Cannabis Stocks to Sell in May While You Still CanMay 26, 2024 | theglobeandmail.comCanopy Gwth: Stocks Overvalued by Analyst Consensus on TSX (WEED)May 22, 2024 | theglobeandmail.comCanopy Gwth: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (WEED)May 21, 2024 | msn.comCannabis Stocks Rally After Rescheduling News: Investment Management Firm Co-Founder Discusses Impact and Next StepsMay 16, 2024 | forbes.comMarijuana Reclassification Bid Sends Cannabis Stocks SoaringMay 16, 2024 | msn.comCanadian cannabis stocks rally as U.S. takes another step toward reclassifying potMay 16, 2024 | benzinga.comCanopy Gwth's Options: A Look at What the Big Money is ThinkingMay 16, 2024 | marketwatch.comCanopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana ReclassificationMay 10, 2024 | msn.comCanopy Growth Stock Is on a Tear: Is it a Good Buy Now?May 9, 2024 | msn.comCanopy Growth’s (NASDAQ:CGC) Stock Surges as it Ramps Up U.S. BusinessMay 7, 2024 | msn.com4 Reasons Canopy Growth Stock Looks Like a Screaming BuyMay 7, 2024 | msn.comCanopy Growth exercises options to buy Wana Brands and Jetty Extracts as it moves into the U.S.May 6, 2024 | fool.ca1 Cannabis Stock to Buy Hand Over Fist and 1 to AvoidMay 3, 2024 | msn.comCanopy Growth Announces Financing Deal Including Roughly $50M Of New Gross ProceedsMay 3, 2024 | marketwatch.comCanopy Growth Secures $50M in New FinancingMay 1, 2024 | msn.comMarijuana Stocks: TLRY and Canopy Growth Gain on DEA AnnouncementMay 1, 2024 | marketwatch.comCannabis stocks settle down after rally on plans to reclassify pot as less dangerousMay 1, 2024 | seekingalpha.comSNDL Rallies On News Of U.S. Rescheduling Of CannabisApril 30, 2024 | finance.yahoo.comPot Stocks Surge on Report DEA Set to Reclassify MarijuanaApril 22, 2024 | finance.yahoo.comConstellation Brands distances itself from Cannabis company Canopy GrowthApril 20, 2024 | morningstar.comConstellation Brands moves itself further away from cannabis grower Canopy Growth's businessSee More Headlines Receive WEED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/31/2024Next Earnings (Estimated)6/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis Current SymbolTSE:WEED CUSIPN/A CIKN/A Webwww.canopygrowth.com Phone+1-613-5999600FaxN/AEmployees2,700Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.20 High Stock Price TargetC$6.70 Low Stock Price TargetC$0.50 Potential Upside/Downside-72.3%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C($21.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.01Net IncomeC$-1,180,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-121.56% Return on Assets-8.89% Debt Debt-to-Equity Ratio127.28 Current Ratio1.79 Quick Ratio2.32 Sales & Book Value Annual SalesC$362.24 million Price / Sales2.40 Cash FlowC$7.10 per share Price / Cash Flow1.63 Book ValueC$6.57 per share Price / Book1.76Miscellaneous Outstanding Shares75,050,000Free FloatN/AMarket CapC$868.33 million OptionableNot Optionable Beta1.85 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Bruce A. Linton (Age 52)Co-Founder, Chairman & Co-CEO Mr. Mark Anthony Nicholas ZekulinPres & Co-CEOMr. Timothy Rob SaundersExec. OfficerMr. Rade KovacevicExec. VPMr. Mike LeeActing Chief Financial OfficerKey CompetitorsCronos GroupCVE:MJNCanniMed TherapeuticsTSE:CMEDOrganigramTSE:OGIEmblemCVE:EMCICC LabsCVE:ICCView All CompetitorsInsidersDavid Angelo LazzaratoSold 38,502 sharesTotal: C$31,186.62 ($0.81/share)David Eric KleinSold 18,775 sharesTotal: C$9,763.00 ($0.52/share)Judy Eun Joo HongSold 1,087 sharesTotal: C$565.24 ($0.52/share)Thomas Carlton StewartSold 19,667 sharesTotal: C$12,193.54 ($0.62/share)David Angelo LazzaratoSold 3,872 sharesTotal: C$2,400.64 ($0.62/share)View All Insider Transactions WEED Stock Analysis - Frequently Asked Questions Should I buy or sell Canopy Growth stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" WEED shares. View WEED analyst ratings or view top-rated stocks. What is Canopy Growth's stock price target for 2024? 4 analysts have issued 12 month target prices for Canopy Growth's stock. Their WEED share price targets range from C$1.30 to C$6.70. On average, they expect the company's share price to reach C$3.78 in the next year. This suggests that the stock has a possible downside of 67.4%. View analysts price targets for WEED or view top-rated stocks among Wall Street analysts. How have WEED shares performed in 2024? Canopy Growth's stock was trading at C$6.76 at the start of the year. Since then, WEED shares have increased by 71.4% and is now trading at C$11.59. View the best growth stocks for 2024 here. When is Canopy Growth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 20th 2024. View our WEED earnings forecast. What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include Aurora Cannabis (ACB), Aphria (APHA), Auxly Cannabis Group (CBWTF), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACBFF), GW Pharmaceuticals (GWPH) and Alibaba Group (BABA). How do I buy shares of Canopy Growth? Shares of WEED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:WEED) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.